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associated with a decreased in receipt of Tx2 and TxS, though this was not 
statistically significant for TxS. CONCLUSIONS: Surgery of the primary tumor 
site and marital status were the most significant clinical variables predicting 
whether elderly beneficiaries proceed to Tx2. Surgery of the primary site was 
only statistically significant for predicting receipt of TxS. Increased age, less than 
6 months of state buy-in, and SEER-registry site were associated with decreased 
receipt of Tx2 and TxS.  
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OBJECTIVES: To evaluate the clinico-pathological characteristics and treatment 
pattern in metastatic breast cancer (MBC) in tertiary care hospital. METHODS: A 
retrospective study was conducted using patient medical records diagnosed with 
metastatic breast cancer from January 2006 to December 2010 and were analyzed 
for clinico-pathological characteristics and treatment patterns. Demographic 
data along with socio-family history, hormonal receptor status, HER2/neu status, 
menopausal status, distant metastasis and treatment were recorded. RESULTS: 
The study included 152 MBC patients, which showed that the majority was seen 
in age-group 25 to 50 years, and the number of postmenopausal women was the 
most observed. Among them there was equal distribution of both estrogen 
receptor (ER) positive and negative patients, while progesterone receptor (PR) 
negative patients were more when compared to positive. HER2/neu status was 
available in 74 patients, among them 32.4% were strongly positive, 35.1% 
patients were weakly positive and 32.4% were negative. Reports on organ 
metastasis were available for 146 patients, among them majority (37.1%) had 
bone metastasis followed by liver metastasis (19.8%). The treatment of MBC 
mainly included systemic chemotherapy and/or hormonal therapy. Palliative 
radiotherapy was given to 59.2% of patients. Anthracycline based 
chemotherapeutic regimens (AC, FAC, CEF) were prescribed the most common 
(88.9 %). Taxanes and capecitabine were prescribed as second line agents. 
However, aromatase inhibitors (1 mg once daily anastrazole, 2.5 mg once daily 
letrozole, and 25 mg once daily exemestane) were prescribed mainly as 
sequential or extended therapy. Bisphosphonate (monthly 4mg zolendronic acid) 
were prescribed among 30.7% of patients. The symptomatic treatments included 
opiates, antiematics, dexamethasone, antidepressant, laxatives, lidocaine, iron 
and calcium supplements. CONCLUSIONS: This study highlights the 
epidemiological, clinico-pathological characteristics of MBC and its treatment 
pattern in a tertiary care hospital in South India.  
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OBJECTIVES: Evidence supporting the use of adjuvant radiation therapy (ART) 
versus salvage RT (SRT) following prostatectomy in prostate cancer patients with 
high-risk disease is inconclusive. We sought to compare and contrast US and 
Italian Radiation Oncologists (RO) beliefs and practices on the use of ART and 
SRT in the treatment of prostate cancer following prostatectomy. METHODS: A 
34-question, web-based survey on post-prostatectomy prostate cancer ART and 
SRT treatment attitudes was distributed to US and Italian RO. Survey invitations 
were e-mailed to a sample of 926 US RO selected from the American Society for 
Radiation Oncology membership directory, and to all 716 Italian RO listed in the 
Italian Association of Radiation Oncology roster. Bivariate, chi-square analyses to 
compare US and Italian RO responses on ART and SRT beliefs and practices were 
performed. RESULTS: The US survey had 218 respondents (24% response rate), 
while the Italian survey had 154 respondents (21.5% response rate). Both US and 
Italian RO routinely recommend ART, but more US than Italian RO would initiate 
ART based solely on adverse pathological features in the prostatectomy 
specimen (79.4% vs. 68.4%, p<0.05). 70% US RO believed ART improves survival 
outcomes compared to 35.5% Italian RO (p<0.05). A striking difference in ART use, 
timing, dosage, and technique was found between Italian and US RO. More US 
RO would initiate salvage therapy based on any detectable PSA compared to 
Italian physicians (36.8% vs. 11.3%, p<0.05); Italian RO, in contrast, were more 
likely than US OR to initiate SRT upon higher PSA levels. CONCLUSIONS: Much 
variation is seen between US and Italian RO in regards to use of ART and SRT in 
prostate cancer patients after prostatectomy. More clinical studies should be 
undertaken in order to provide better evidence on ART versus SRT use in clinical 
practice.  
 
PCN155  
PROSTATE CANCER IN ARGENTINA: TREATMENT PATTERNS AND  
HEALTH CARE RESOURCES UTILIZATION. RESULTS OF A LOCAL PHYSICIAN 
SURVEY  
Peirano I1, Soriano MA2, Gonzalez Michaca L3, Fontanet R1, Roel G1 
1Janssen, Buenos Aires, Argentina, 2IMS Health Mexico, Mexico City, Mexico, 3Janssen, México, 
Mexico  
OBJECTIVES: There is limited up-to-date available data examining the real-world 
treatment practices of prostate cancer (PC). The primary objective of this study is 
to describe treatment patterns, as well as resources utilization for PC in 
Argentina during 2012. METHODS: An in-depth face to face survey was 
conducted. Eligibility criteria included: oncologist, urologist or uro-oncologist; 
clinical experience in oncologic treatment of PC, including hormonal therapy; 
minimum patient volume of 30 PC patients at the moment of the enrollment in 
the survey; have high reputation as key opinion leaders. Results were analyzed 
and weighted according to the volume of patients each physician attended. 
RESULTS: Ten physicians (80% oncologist, 10% urologist, 10% uro-oncologist), 
mainly from the private sector (79% vs. 21%), with an average of 22 years of 
experience and currently treating an average of 44 patients were interviewed. 
The most common reason for consultation with the specialist was an abnormal 
PSA result. A total of 40% of patients were diagnosed with metastatic PC and 
immediately after, androgen deprivation therapy was started. In patients with 
localized PC, most doctors take patient’s preference into account (75% of their 
patients) in the choice of the treatment, and as the risk increased, radical 
prostatectomy was more commonly used. The most common treatment pattern 
in hormone therapy was the combination of a GnRH analogue and 
antiandrogens. In castration resistant PC, docetaxel is the most common 1st line 
therapy and mitoxantrone the 2nd line, followed by abiraterone. Health care 
resource utilization such as blood tests/year (complete blood count, blood 
chemistry, functional liver tests, PSA), some imaging tests/year, specialist visits 
and hospitalizations increases as disease progresses. CONCLUSIONS: Treatment 
pattern of PC in Argentina follow International Guidelines, and resource 
utilization increases as the disease progresses.  
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OBJECTIVES: Examine the associations between severity of chronic kidney 
disease (CKD) in patients with Type 2 diabetes, the probability of being 
hospitalized, and hospital length of stay (LOS). METHODS: This study utilized 
data from Humedica electronic medical records, captured in the period January 
1, 2007 through September 30, 2011. Patients eligible for this study were 
diagnosed with both CKD (ICD-9-CM 585.1-585.6) and Type 2 diabetes, and aged 
≥21yrs as of September 30, 2011. Logistic regression analyzed the relationship 
between CKD severity and the probability of hospitalization, while a negative 
binomial regression examined the relationship between CKD severity and 
hospital LOS. All analyses controlled for patient demographic characteristics, 
baseline antidiabetic therapy, baseline HbA1c levels, patient general health, and 
comorbidities. RESULTS: 3,406 individuals met the inclusion criteria: 687 with 
mild (ICD-9 585.1, 585.2; 1,981 moderate (585.3); and 425 severe CKD (585.4, 585.5); 
313 patients had end stage renal disease (ESRD) (585.6). Generally, patients with 
severe CKD or ESRD, compared to mild/moderate CKD, were more likely to be 
African-American, reside in the Midwest or South, have Medicaid insurance or 
be uninsured, and have received a prescription for insulin at baseline. Further, 
such patients were less likely to have commercial insurance, “good” glycemic 
control (HbA1c ≤7), or be using an oral antidiabetic therapy at baseline. Adjusted 
Odds Ratios (OR) showed that, compared to mild CKD, both severe CKD and ESRD 
were associated with a significantly higher likelihood of hospitalization in the 2 
year post index date (Severe: OR=2.040, 95% CI 1.531 – 2.720; ESRD: OR=2.910, 95% 
CI 2.071 – 4.088). Similarly, moderate CKD, severe CKD and ESRD were asso-
ciated with significantly longer LOS compared to mild CKD (Moderate: 
Coefficient=0.2431, P=0.0259; Severe: Coefficient=0.8081, P<0.0001; ESRD: 
Coefficient=1.1237, P<0.0001). CONCLUSIONS: As severity of CKD increases in 
patients with type 2 diabetes, the likelihood of hospitalization increases as does 
the need for inpatient resource utilization.  
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OBJECTIVES: Greater comorbidity burden is correlated with poor patient 
outcomes among individuals with diabetes, but which condition clusters are 
most prevalent remains unclear. By identifying the most common multiple 
chronic condition (MCC) patterns, this study could help prioritize comorbidities 
to be addressed by clinical guidelines. METHODS: We conducted cross-sectional 
analysis of the 2008-2012 Humedica dataset containing information from 
electronic health records, encounter data, and lab values supplied by provider 
networks across the U.S. Our cohort included adults (aged ≥18 years) with type 2 
diabetes and at least 24 months of ambulatory and hospital data (n=162,332). Of 
the 14 comorbidities listed in the 2012 American Diabetes Association guidelines, 
we selected the eight conditions that each affected ≥10% of the patients and 
analyzed the most common patterns of MCCs by age group. RESULTS: 89.1% of 
diabetes patients had at least one comorbidity and 40.9% had three or more. 
Conditions with a prevalence rate ≥10% included hypertension (74.7%), 
hyperlipidemia (65.8%), coronary artery disease (CAD, 17.7%), cancers (17.1%), 
COPD/asthma (14.2%), arthritis (14.0%), chronic kidney disease (CKD, 12.0%), and 
depression (11.4%). The leading combination was hypertension and 
hyperlipidemia only, accounting for 21.1% of the population, followed by 
hypertension only (10.9%), hyperlipidemia only (5.0%), and the combination of 
hypertension and hyperlipidemia plus CAD (4.7%). Older adults (≥65 years) were 
more likely than younger adults (<65 years) to have all comorbidities except 
depression (7.6% vs. 10.1%, p=<0.0001), though the condition rankings were 
similar in both groups. CONCLUSIONS: Diabetes patients have substantial 
